Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (71-80 of 299) with videos related to

Pageof 30
Sort By:
Leukemia & Lymphoma|November 15, 2018
A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with PalbociclibNagendra K Chaturvedi, Nathan D Hatch, Garrett L Sutton, et al.
Leukemia & Lymphoma|April 25, 2007
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantationJulie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphomaJulie M Vose, Philip J Bierman, Charles Enke, et al.
Oncology (Williston Park, N.Y.)|March 18, 2005
Follicular lymphoma: expanding therapeutic optionsApar Kishor Ganti, R Gregory Bociek, Philip J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2017
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research StatementLaura A Levit, Raymond P Perez, David C Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-054: Long Term Follow Up of Patients Undergoing High Dose Chemotherapy and Autologous or Allogeneic Stem Cell Transplantation for Mantle Cell LymphomaSandra Amponsah Frimpong, Valerie Shostrom, Robert Gregory Bociek, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2017
Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based StudySmith Giri, Vijaya Raj Bhatt, Vivek Verma, et al.
Leukemia & Lymphoma|July 16, 2009
Advances in mobilization for the optimization of autologous stem cell transplantationJulie M Vose, Anthony D Ho, Bertrand Coiffier, et al.
American Journal of Hematology|January 4, 2012
Sarcoidosis mimicking recurrent lymphomaWei Li, Karen Holdeman, Javier A Laurini, et al.
British Journal of Haematology|January 10, 2012
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphomaZdravko Mitrovic, Martin Bast, Philip J Bierman, et al.
Pageof 30

Showing results (71-80 of 299) with videos related to

Sort By:
Pageof 30
Leukemia & Lymphoma|November 15, 2018
A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with PalbociclibNagendra K Chaturvedi, Nathan D Hatch, Garrett L Sutton, et al.
Leukemia & Lymphoma|April 25, 2007
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantationJulie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphomaJulie M Vose, Philip J Bierman, Charles Enke, et al.
Oncology (Williston Park, N.Y.)|March 18, 2005
Follicular lymphoma: expanding therapeutic optionsApar Kishor Ganti, R Gregory Bociek, Philip J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2017
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research StatementLaura A Levit, Raymond P Perez, David C Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-054: Long Term Follow Up of Patients Undergoing High Dose Chemotherapy and Autologous or Allogeneic Stem Cell Transplantation for Mantle Cell LymphomaSandra Amponsah Frimpong, Valerie Shostrom, Robert Gregory Bociek, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2017
Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based StudySmith Giri, Vijaya Raj Bhatt, Vivek Verma, et al.
Leukemia & Lymphoma|July 16, 2009
Advances in mobilization for the optimization of autologous stem cell transplantationJulie M Vose, Anthony D Ho, Bertrand Coiffier, et al.
American Journal of Hematology|January 4, 2012
Sarcoidosis mimicking recurrent lymphomaWei Li, Karen Holdeman, Javier A Laurini, et al.
British Journal of Haematology|January 10, 2012
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphomaZdravko Mitrovic, Martin Bast, Philip J Bierman, et al.
Pageof 30